Journal Of Muscle Research And Cell Motility

杂志介绍

Journal Of Muscle Research And Cell Motility杂志介绍

《Journal Of Muscle Research And Cell Motility》是一本以English为主的未开放获取国际优秀期刊，中文名称肌肉研究与细胞运动杂志，本刊主要出版、报道生物学-CELL BIOLOGY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为1.8，最新CiteScore 指数为6.2。

本刊近期中国学者发表的论文主要有：

• Specific effects of neuregulin-1β on the communication between DRG neurons and skeletal muscle cells in vitro

  Author: Menglin Cong, Jianmin Li, Yuan Qiao, Rui Jing, Hao Li, Zhenzhong Li

• Introducing a special edition of the Journal of Muscle Research and Cell Motility on tropomyosin: form and function

  Author: Steven Marston, Matthias Gautel

• A re-interpretation of the rate of tension redevelopment ( kTR) in active muscle

  Author: Li Wang, Masataka Kawai

• A rat model study of atrophy of denervated musculature of the hand being faster than that of denervated muscles of the arm

  Author: Ji-xin Wu, Liang Chen, Fei Ding, Yu-dong Gu

英文介绍

Journal Of Muscle Research And Cell Motility杂志英文介绍

The Journal of Muscle Research and Cell Motility has as its main aim the publication of original research which bears on either the excitation and contraction of muscle, the analysis of any one of the processes involved therein, the processes underlying contractility and motility of animal and plant cells, the toxicology and pharmacology related to contractility, or the formation, dynamics and turnover of contractile structures in muscle and non-muscle cells. Studies describing the impact of pathogenic mutations in genes encoding components of contractile structures in humans or animals are welcome, provided they offer mechanistic insight into the disease process or the underlying gene function. The policy of the Journal is to encourage any form of novel practical study whatever its specialist interest, as long as it falls within this broad field. Theoretical essays are welcome provided that they are concise and suggest practical ways in which they may be tested. Manuscripts reporting new mutations in known disease genes without validation and mechanistic insight will not be considered. It is the policy of the journal that cells lines, hybridomas and DNA clones should be made available by the developers to any qualified investigator. Submission of a manuscript for publication constitutes an agreement of the authors to abide by this principle.